Counter CM - Search Results

1

CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment.

Klomp JE, Lee YS, Goodwin CM, Papke B, Klomp JA, Waters AM, Stalnecker CA, DeLiberty JM, Drizyte-Miller K, Yang R, Diehl JN, Yin HH, Pierobon M, Baldelli E, Ryan MB, Li S, Peterson J, Smith AR, Neal JT, McCormick AK, Kuo CJ, Counter CM, Petricoin EF 3rd, Cox AD, Bryant KL, Der CJ. Klomp JE, et al. Among authors: counter cm. Cell Rep. 2021 Nov 30;37(9):110060. doi: 10.1016/j.celrep.2021.110060. Cell Rep. 2021. PMID: 34852220 Free PMC article.

2

Characterization of the repeat-tract instability and mutator phenotypes conferred by a Tn3 insertion in RFC1, the large subunit of the yeast clamp loader.

Xie Y, Counter C, Alani E. Xie Y, et al. Genetics. 1999 Feb;151(2):499-509. doi: 10.1093/genetics/151.2.499. Genetics. 1999. PMID: 9927446 Free PMC article.

3

Distinct requirements for Ras oncogenesis in human versus mouse cells.

Hamad NM, Elconin JH, Karnoub AE, Bai W, Rich JN, Abraham RT, Der CJ, Counter CM. Hamad NM, et al. Among authors: counter cm. Genes Dev. 2002 Aug 15;16(16):2045-57. doi: 10.1101/gad.993902. Genes Dev. 2002. PMID: 12183360 Free PMC article. Review.

4

Activation of RalA is critical for Ras-induced tumorigenesis of human cells.

Lim KH, Baines AT, Fiordalisi JJ, Shipitsin M, Feig LA, Cox AD, Der CJ, Counter CM. Lim KH, et al. Among authors: counter cm. Cancer Cell. 2005 Jun;7(6):533-45. doi: 10.1016/j.ccr.2005.04.030. Cancer Cell. 2005. PMID: 15950903 Free article.

5

Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance.

Lim KH, Counter CM. Lim KH, et al. Among authors: counter cm. Cancer Cell. 2005 Nov;8(5):381-92. doi: 10.1016/j.ccr.2005.10.014. Cancer Cell. 2005. PMID: 16286246 Free article.

6

Use of retrovirus expression of interfering RNA to determine the contribution of activated K-Ras and ras effector expression to human tumor cell growth.

Baines AT, Lim KH, Shields JM, Lambert JM, Counter CM, Der CJ, Cox AD. Baines AT, et al. Among authors: counter cm. Methods Enzymol. 2006;407:556-74. doi: 10.1016/S0076-6879(05)07045-X. Methods Enzymol. 2006. PMID: 16757353

7

Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells.

Lim KH, O'Hayer K, Adam SJ, Kendall SD, Campbell PM, Der CJ, Counter CM. Lim KH, et al. Among authors: counter cm. Curr Biol. 2006 Dec 19;16(24):2385-94. doi: 10.1016/j.cub.2006.10.023. Curr Biol. 2006. PMID: 17174914 Free article.

8

Aurora-A phosphorylates, activates, and relocalizes the small GTPase RalA.

Lim KH, Brady DC, Kashatus DF, Ancrile BB, Der CJ, Cox AD, Counter CM. Lim KH, et al. Among authors: counter cm. Mol Cell Biol. 2010 Jan;30(2):508-23. doi: 10.1128/MCB.00916-08. Epub 2009 Nov 9. Mol Cell Biol. 2010. PMID: 19901077 Free PMC article.

9

RALA and RALBP1 regulate mitochondrial fission at mitosis.

Kashatus DF, Lim KH, Brady DC, Pershing NL, Cox AD, Counter CM. Kashatus DF, et al. Among authors: counter cm. Nat Cell Biol. 2011 Aug 7;13(9):1108-15. doi: 10.1038/ncb2310. Nat Cell Biol. 2011. PMID: 21822277 Free PMC article.

10

Targeting eNOS in pancreatic cancer.

Lampson BL, Kendall SD, Ancrile BB, Morrison MM, Shealy MJ, Barrientos KS, Crowe MS, Kashatus DF, White RR, Gurley SB, Cardona DM, Counter CM. Lampson BL, et al. Among authors: counter cm. Cancer Res. 2012 Sep 1;72(17):4472-82. doi: 10.1158/0008-5472.CAN-12-0057. Epub 2012 Jun 27. Cancer Res. 2012. PMID: 22738914 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page